Publicacións en colaboración con investigadores/as de University of Toronto (30)

2023

  1. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

    Annals of the rheumatic diseases, Vol. 82, Núm. 5, pp. 698-709

  2. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    Annals of the Rheumatic Diseases

2021

  1. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 3, pp. 593-600

  2. European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 775-781

  3. The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?

    Arthritis Care and Research, Vol. 73, Núm. 6, pp. 856-860

2020

  1. Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

    Current Therapeutic Research - Clinical and Experimental, Vol. 93

  2. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 10, pp. 1333-1339

2019

  1. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159

2017

  1. A survey of anatomical items relevant to the practice of rheumatology: pelvis, lower extremity, and gait

    Clinical Rheumatology, Vol. 36, Núm. 12, pp. 2813-2819

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977

2016

  1. A survey of anatomical items relevant to the practice of rheumatology: upper extremity, head, neck, spine, and general concepts

    Clinical Rheumatology, Vol. 35, Núm. 12, pp. 3025-3030

2015

  1. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

    Nature Communications, Vol. 6

2014

  1. Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 2, pp. 328-335

  2. The efficacy and safety of treatments for acute gout: Results from a series of systematic literature reviews including cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors

    Journal of Rheumatology, Vol. 41, Núm. SUPPL. 92, pp. 15-25

2013

  1. Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 1, pp. 83-88

2012

  1. Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

    Arthritis and Rheumatism, Vol. 64, Núm. 8, pp. 2504-2517

  2. Treating rheumatoid arthritis to target: Recommendations of an international task force

    Revmatologiia (Bulgaria), Vol. 20, Núm. 2, pp. 5-16

2011

  1. Algorithm for identification of undifferentiated peripheral inflammatory arthritis: A multinational collaboration through the 3e initiative

    Journal of Rheumatology, Vol. 38, Núm. SUPPL. 87, pp. 54-58

  2. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 404-413

  3. American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 573-586